VIKING THERAPEUT.DL -,005 WKN: A12GD6 ISIN: US92686J1060 Kürzel: VKTX Forum: Aktien Thema: Hauptdiskussion
Up to 75% of Patients Treated with VK2809 Achieved NASH Resolution with No Worsening of Fibrosis as Compared to 29% for Placebo (p=0.0001) Up to 57% of VK2809-Treated Patients Achieved ≥1-Stage Improvement in Fibrosis with No Worsening of NASH as Compared to 34% for Placebo (p<0.05) Up to 48% of VK2809-Treated Patients Achieved Both Resolution of NASH and a ≥1-Stage Improvement in Fibrosis as Compared to 20% for Placebo (p=0.01) Adverse Events, Including GI-Related AEs, Similar Among VK2809-Treated Patients vs. Placebo at Week 52; Consistent with Prior Data Reported at Week 12 Conference Call Scheduled for 8:00 a.m. ET Today
|
Thema | ||
---|---|---|---|
1 | SOLAREDGE TECH Hauptdiskussion | +1,08 % | |
2 | Trading- und Aktien-Chat | ||
3 | Exela 2023 sachliches Forum | -32,32 % | |
4 | MicroStrategy | -0,50 % | |
5 | RHEINMETALL Hauptdiskussion | +5,10 % | |
6 | Dax Prognose | +1,05 % | |
7 | OCUGEN NEWS | +6,34 % | |
8 | MODERNA INC. DL-,0001 Hauptdiskussion | +8,88 % | |
9 | JUMIA TECH. SP.ADR/2 O.N. Hauptdiskussion | -17,43 % | |
10 | NVIDIA Hauptdiskussion | -0,10 % | Alle Diskussionen |
|
Thema | ||
---|---|---|---|
1 | SOLAREDGE TECH Hauptdiskussion | +1,08 % | |
2 | Exela 2023 sachliches Forum | -32,32 % | |
3 | MicroStrategy | -0,50 % | |
4 | RHEINMETALL Hauptdiskussion | +5,10 % | |
5 | OCUGEN NEWS | +6,34 % | |
6 | MODERNA INC. DL-,0001 Hauptdiskussion | +8,88 % | |
7 | JUMIA TECH. SP.ADR/2 O.N. Hauptdiskussion | -17,43 % | |
8 | NVIDIA Hauptdiskussion | -0,10 % | |
9 | SMA SOLAR Hauptdiskussion | -0,25 % | |
10 | FREYR BATTERY | ±0,00 % | Alle Diskussionen |